adagrasib
mirati
['nsclc', 'lcsm,(-blcsm)', 'sclc', 'adagrasib']
adagrasib improves outcomes in kras-mutated nsclc, phase ii study shows #lcsm #oncology #cancer #asco22
News and views from the world of clinical oncology and hematology